Skip to main content
Erschienen in: BMC Neurology 1/2014

Open Access 01.12.2014 | Research article

Neuropsychological outcome after carbon monoxide exposure following a storm: a case-control study

verfasst von: Bérengère Pages, Mélanie Planton, Sophie Buys, Béatrice Lemesle, Philippe Birmes, Emmanuel Joseph Barbeau, Stéphanie Maziero, Laurie Cordier, Claudine Cabot, Michèle Puel, Michèle Genestal, François Chollet, Jérémie Pariente

Erschienen in: BMC Neurology | Ausgabe 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

The cognitive consequences of carbon monoxide (CO) poisoning are well described. However, most studies have been carried out without an ad-hoc group of control subjects. The main aim of this study was to evaluate cognitive and psychiatric outcome after CO exposure during the storm Klaus in the South West of France (January 2009) in a homogeneous group of patients compared to a group of 1:1 paired controls.

Methods

Patients and controls were asked to fill out questionnaires about quality of life and cognitive complaints. They then underwent a cognitive assessment derived from the Carbon Monoxide Neuropsychological Screening Battery. Psychiatric assessment was performed using subtests of the Mini International Neuropsychiatric Interview.

Results

38 patients and 38 paired controls were included (mean age 38.8 years) and evaluated 51 days after the poisoning. No difference was found between groups on the cognitive complaint questionnaire but patients had a lower quality of life than controls. Patients showed significantly lower cognitive performance than controls on processing speed, mental flexibility, inhibition and working and verbal episodic memories. Patients were more depressed than controls, and suffered more from post-traumatic stress disorder.

Conclusions

We report the first study investigating cognitive and psychiatric outcome in consecutive patients after CO poisoning during a natural disaster, using a group comparison method. CO poisoning during storms needs to be dealt with adequately and clinicians should be aware of its possible consequences.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2377-14-153) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

BP participated in the design of the study, assessed patients’ neuropsychological functions and performed analysis and interpretation of data. MPlanton performed the statistical analysis and helped draft the manuscript. SB assessed patients’ neuropsychological functions and performed analysis and interpretation of data. BL participated in the design of the study and helped assess patients’ cognitive functions. PB met all subjects and performed their psychiatric assessment. EJB participated in the design of the study and analysis of data and was involved in drafting the manuscript. SM recruited and assessed control subjects’ neuropsychological functions. LC assessed patients’ neuropsychological functions and performed analysis and interpretation of data. CC participated in the design of the study. MPuel performed neurological assessment and participated in the design of study. MG participated in the design of the study. FC performed neurological assessment and participated in the design of study. JP conceived the study, performed neurological assessment and was involved in drafting the manuscript. All authors read and approved the final manuscript.

Background

The cognitive consequences of carbon monoxide (CO) poisoning are well described [1]. They can be observed during the acute phase of the poisoning, after a few days and persist for over a year [26]. They mainly involve memory, attention, processing speed and executive functions [6]. However, most studies have been carried out without an ad-hoc group of control subjects, mainly relying on published norms for comparison [7, 8]. Interestingly, Deschamps et al. did not evidence any difference between patients and controls when a specific group of controls was recruited [9]. These last studies gathered patients with variable circumstances of CO intoxication, which may be the reason for their heterogeneous results, but which also questions the extent to which results apply to all patients. It was to avoid these limitations that we carried out the present study in a homogenous group of intoxicated patients using rigorously selected control subjects.
The storm Klaus reached the South West of France between 23rd and 25th January 2009 leaving 1,745,000 households without electricity. It is considered to be the most violent storm in France in the past decade, resulting in 1.2 billion Euros of structural damage. Alternative means of heating and lighting, including electricity generators, were used and resulted in increased CO poisoning. 117 persons were poisoned in the Midi-Pyrenean region and referenced by the local specialized center.
The main aim of this study was to evaluate cognitive and psychiatric outcome after CO exposure during the Klaus storm in a homogeneous group of patients and to compare the results with those obtained in a group of controls paired 1:1 to patients for age, gender and education level.

Methods

Subjects

We contacted 117 poisoned patients by phone to invite them to participate in the present study. We invited them to attend an outpatient clinic for a cognitive and psychiatric assessment in the Purpan hospital, Toulouse, France.
Patients were eligible for the study if they met the following criteria: 1) A diagnosis of CO poisoning according to the published criteria of documented exposure to carbon monoxide or obvious exposure to carbon monoxide with observation of any of the following symptoms: loss of consciousness, confusion, headache, malaise, fatigue, forgetfulness, dizziness, visual disturbances, nausea, vomiting, cardiac ischemia, or metabolic acidosis [6]. If the carboxyhemoglobin level was below 10 percent, the patient was eligible only if carbon monoxide poisoning was the only plausible diagnosis, 2) Above 15 years of age, 3) French language abilities good enough to undergo the assessment, 4) Signed informed consent. Non-inclusion criteria were: patients admitted to a nursing home, patients with a preexisting chronic neurological illness or with depression or post-traumatic stress disorder, patients with a life threatening condition and patients with hypoxia due to a chemical intoxication. Patients who suffered from any medical condition, other intoxication or brain traumatism between CO poisoning and the assessment in the present study were not included. When possible, carboxyhemoglobin (COHb) level was recorded. A CT scan was performed when necessary at the acute phase.

Procedure

The included patients were asked to fill out cognitive complaint and quality of life questionnaires [10, 11]. They then underwent general and neurological clinical examinations, which included a semi-structured interview. A cognitive assessment derived from the Carbon Monoxide Neuropsychological Screening Battery was performed: Free and Cued Selective Reminding Test (FCSRT) for verbal episodic memory, WAIS-III Letter-Number Sequencing for working memory, MEM-III orientation test, WAIS-III Digit Symbol Test, TMT A and B, Stroop test for executive functions, and confrontation naming test for language [4]. In accordance with the literature, 8 specific variables of interest were identified within this battery: the cued and total 3 recall of the FCSRT (score/48), the raw score for Letter-Number Sequencing (/21), the raw score of the orientation test (/14), the raw score for digit substitution in the Digit Symbol Test (/133), time in seconds for TMT B-A, reading time in seconds for the score interference part of the Stroop test and the raw score for naming in the confrontation naming test (/10) [68]. Psychiatric assessment was performed using subtests of the Mini International Neuropsychiatric Interview (M.I.N.I. 5.0.0): major depressive episode (MDE), manic episode, hypomanic episode, post-traumatic stress disorder (PTSD), psychotic disorders, and antisocial personality disorder [12]. The total time of the evaluation was approximately 1 hour.
A group of controls not exposed to carbon monoxide was enrolled in the study. They were relatives of patients seen in our memory clinic. They were paired 1:1 to patients for age, gender, and level of education. Controls received exactly the same evaluation tests as patients.
Patients and controls gave their informed consent for this study. The study was approved by the local ethics committee (“Comité d’Ethique de la Recherche” of the Toulouse teaching hospital “CHU de Toulouse”, France).

Statistical analysis

We performed an intergroup comparison on demographic and clinical data using bilateral Student t tests for independent samples, non-parametric Mann-Whitney U tests when a Kolmogorov-Smirnov test indicated that the sample did not follow a normal distribution, or a chi2 test when appropriate. Effect size was estimated using Cohen’s D [13] when a significant difference was observed. Following conventional criteria, an effect size of 0.20 to 0.30 was considered “small”, around 0.50 “medium” and above 0.80 “large”. In the patients’ group, we used Spearman correlation between COHb level and cognitive composite score. The cognitive composite score was generated from the 8 specific variables of interest previously identified (the cued and total 3 recall of the FCSRT, the raw score for Letter-Number Sequencing, the raw score for the orientation test, the raw score for digit substitution in the Digit Symbol Test, time in seconds for TMT B-A, reading time in seconds for the score interference part of the Stroop test and the raw score for naming in the confrontation naming test). For each of the 8 variables, the patients’ scores were standardized according to the group average of the variable. Then, the cognitive composite score was calculated as the mean of the 8 standardized cognitive scores. The lower the cognitive composite score, the more severe the cognitive impairment. p < 0.05 was considered statistically significant.

Results

Among the 117 patients, 30 were children under 15 who were not contacted. 87 patients were contacted by phone between February 25th and 27th 2009. 7 did not meet the inclusion criteria. The 80 remaining persons were contacted and invited to participate. 42 persons did not want to enter the study and explained they had resumed their life with no sequelae. 38 persons were included (mean age 38.9 ± 16.6; 34.2% male; 11.7 ± 2.9 years of education). 38 paired controls were also recruited (mean age 38.7 ± 16.5; 34.2 % male; 11.4 ± 3.9 years of education). No difference was found between patients and controls for age, gender and education level (Figure 1, data reported for education). Patients were assessed for the study 50.9 ± 17.3 days after CO poisoning. They all fulfilled the CO poisoning diagnosis criteria. The COHb level was recorded for 24 out of the 38 patients (10.9% (±7.9)). No CT scan lesion was observed. 2 patients (5%) had received hyperbaric oxygen therapy, 6 (16%) had had normobaric oxygen therapy and 29 (76%) had received both. For 1 patient, the treatment received was not known. Causes of CO intoxication, initial symptoms and symptoms reported during the semi-structured interview are reported in Table 1.
Table 1
Causes of CO poisoning, initial symptoms and symptoms observed during the study
Cause of CO poisoning
 
Electric generator
58%
Gas heater
29%
Charcoal heater
8%
Gas water heater
5%
Initial symptoms*
 
Headache
82%
Dizziness
55%
Nausea
53%
Fatigue
29%
Loss of consciousness
29%
Cardiac ischemia
10%
Severe ketoacidosis
3%
Acute pulmonary edema
3%
Symptoms during study evaluation
Headache
47%
Fatigue
45%
Feeling sad
39%
Concentration difficulties
39%
Feeling apathetic
32%
Experiencing reviviscences
32%
Memory complaint
26%
Reduction of daily activities
26%
Still on sick leave
24%
*No patient presented paralysis, ventricular arrhythmia, convulsion, shock, coma, stroke or rhabdomyolysis as initial symptoms. No brain lesions assessed by CT scan was reported.
No difference was found between groups on the cognitive complaint questionnaire but patients had a lower quality of life than controls (patients: 103.8 ± 18.3; controls: 113.4 ± 9.2; p < 0.001; Table 2). Patients showed significantly lower cognitive performance than controls on 5/8 of the following cognitive variables of interest: FCSRT, letter-number sequences, digit symbol test, TMT B test, Stroop test (Figure 1). The effect size was “medium” for all these tests (Figure 1). Different results between the two groups were identified in two of the six subtests of the M.I.N.I.: major depressive disorder (p < 0.01) and PTSD (p < 0.02) were more common in the patient group (Table 2).
Table 2
Patients’ and controls’ cognitive, psychiatric and global scores
 
Patients
Controls
p value
Cohen’s D
(n = 38)
(n = 38)
Cognitive assessment
    
Disorientation in time and space (MEM III)
   
  MEM III, orientation (/14)
13.76 (±0.48)
13.86 (±0.34)
0.281
-
Memory
    
Free recall
    
  FCRST (sum of 3 free recall, /48)
11.21 (±2.30)
11.86 (±2.32)
0.048
0.47
  FCRST (delayed free recall, /16)
13 (±2.02)
13.92 (±1.51)
0.028
0.52
Cued recall
    
  FCSRT (sum of 3 total recall, /48)
14.63 (±1.66)
15.36 (±0.88)
0.030
0.55
  FCSRT (delayed total recall, /16)
15.63 (±0.91)
15.92 (±0.35)
0.073
-
Executive functions
    
Processing speed
    
  TMT A time
36.73 (±17.64)
31.13 (±12.04)
0.110
-
  Stroop test (denomination time)
64.21 (±14.58)
59.05 (±8.39)
0.063
-
  Stroop test (reading time)
48.31 (±10.07)
41.71 (±6.54)
0.001
0.79
  Digit symbol test (/133)
67.92 (±17.80)
76.71 (±17.74)
0.034
0.49
Working memory
    
  Letter-Number sequencing (WAIS III, /21)
9.97 (±2.56)
11.36 (±2.36)
0.016
0.57
Flexibility
    
  TMTB time
36.73 (±17.64)
31.13 (±12.04)
0.010
0.63
  TMT B-A time
54.55 (±43.57)
32.24 (±24.13)
0.008
0.64
  TMT B-A Errors
0.08 (±0.68)
0.13 (±0.34)
0.685
-
Inhibition
    
  Stroop test (interference score, time)
59.65 (±38.36)
39.86 (±21.37)
0.007
0.61
  Stroop test (interference score, non-corrected errors)
0.47 (±1.51)
0.02 (±0.16)
0.013
0.59
Language
    
  Denomination (/10)
9.95(±0.23)
9.95 (±0.23)
1.000
-
Psychiatric assessment
    
  MNI, major depressive episode, n (%)
8 (21.05%)
0
0.003
-
  MNI, manic episode, n (%)
2 (5.26%)
1 (2.63%)
0.556
-
  MNI, hypomanic episode, n (%)
2 (5.26%)
0
0.152
-
  MNI, post-traumatic stress disorder, n (%)
6 (15.78%)
0
0.011
-
  MNI, psychotic disorders, n (%)
1 (2.63%)
0
0.314
-
  MNI, antisocial personality disorder, n (%)
0
0
-
-
Global assessment
    
Cognitive complaints
    
  Mc Nair score (/45)
11.56 (±7.97)
13.52 (±5.00)
0.206
-
Quality of life
    
 MOS SF-36, Total (/135)
103.81 (±18.37)
113.42 (±9.29)
0.020
0.69
MEM III, Wechsler Memory Scale; FCRST, Free and Cued Selective Reminding Test ; WAIS III, Wechsler Adult Intelligence Scale; TMT, Trail Making Test; MINI, Mini International Neuropsychiatric Interview; MOS SF-36, Medical outcome Study Short Form 36.
We found a negative correlation between patients’ COHb level and cognitive composite score (r = -0,42, p < 0,005) (Figure 2).

Discussion

In this controlled study, patients were all poisoned during the same weather event and over a very short period of time (3 days). They were enrolled and assessed about 7 weeks after the intoxication. In this homogeneous group of patients, we evidenced both cognitive and psychiatric sequelae after CO poisoning.
Performance was significantly lower in patients than in controls in five out of the eight cognitive variables of interest, despite the fact that controls and patients had been rigorously matched. Three of the variables assessed processing speed and executive functions, one working memory and one verbal episodic memory. These results suggest that these patients were suffering from multi-domain cognitive impairment. We are aware of only two studies in which a group of patients was compared to a group of matched controls specifically enrolled for the study [9, 2]. Surprisingly, in Deschamps’ study no cognitive difference was reported between the two groups but not all the patients underwent cognitive assessment [9]. Significant differences were showed in Chen’s study but neuropsychological assessment was only partial and memory function had not been assessed [2]. Other studies investigating cognitive outcome after CO poisoning did not specifically enroll a group of control subjects but reported results that are in accordance with ours [5, 7, 14, 15]. We acknowledge that our study is cross-sectional. Therefore we did not address the delayed neuropsychological impairment issue. The cause of intoxication may be the reason for this apparent difference as previous studies have often included patients who sustained voluntary CO poisoning during suicide attempts, which is a more severe exposure than the involuntary intoxication that happened in our sample.
Psychiatric sequelae such as anxiety and depression have only been reported in a few studies [8, 14]. Patients in our sample also reported PTSD after CO poisoning. This is congruent with the patients’ complaints about their reviviscences.
It is possible that the recruitment method was a factor of bias. The 42 intoxicated persons who did not enter the study might have had lower cognitive impairment compared to the 38 recruited intoxicated participants. Therefore, the size of the observed effects in our analysis is possibly overestimated. However, we have shown that cognitive complaint was as low in the patient group as it was in the group of controls. We acknowledge that if the recruitment method was not ideal, its influence on the results was probably weak.

Conclusions

We report here the first study investigating cognitive and psychiatric outcome in consecutive patients after CO poisoning during a natural disaster. Using a group comparison method, we confirmed the potential multi-domain cognitive nature of sequelae PTSD is one aspect that is also to be taken into account after that specific intoxication. In spite of the medium size effect reported in this study, patients as a group reported a lower quality of life, which may have been caused by these cognitive and psychiatric sequelae. CO poisoning during storms must therefore be dealt with adequately and clinicians should be aware of its possible consequences.

Acknowledgements

We thank Virgina Clark for the English’s technical writing assistance.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​ ) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

BP participated in the design of the study, assessed patients’ neuropsychological functions and performed analysis and interpretation of data. MPlanton performed the statistical analysis and helped draft the manuscript. SB assessed patients’ neuropsychological functions and performed analysis and interpretation of data. BL participated in the design of the study and helped assess patients’ cognitive functions. PB met all subjects and performed their psychiatric assessment. EJB participated in the design of the study and analysis of data and was involved in drafting the manuscript. SM recruited and assessed control subjects’ neuropsychological functions. LC assessed patients’ neuropsychological functions and performed analysis and interpretation of data. CC participated in the design of the study. MPuel performed neurological assessment and participated in the design of study. MG participated in the design of the study. FC performed neurological assessment and participated in the design of study. JP conceived the study, performed neurological assessment and was involved in drafting the manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Prockop LD, Chichkova RI: Carbon monoxide intoxication: an updated review. J Neurol Sci. 2007, 262 (1): 122-130.CrossRefPubMed Prockop LD, Chichkova RI: Carbon monoxide intoxication: an updated review. J Neurol Sci. 2007, 262 (1): 122-130.CrossRefPubMed
2.
Zurück zum Zitat Chen HL, Chen PC, Lu CH, Hsu NW, Chou KH, Lin CP, Wu RW, Li SH, Cheng YF, Lin WC: Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study. BMC Neurol. 2013, 13 (1): 129-10.1186/1471-2377-13-129.CrossRefPubMedPubMedCentral Chen HL, Chen PC, Lu CH, Hsu NW, Chou KH, Lin CP, Wu RW, Li SH, Cheng YF, Lin WC: Structural and cognitive deficits in chronic carbon monoxide intoxication: a voxel-based morphometry study. BMC Neurol. 2013, 13 (1): 129-10.1186/1471-2377-13-129.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Amitai Y, Zlotogorski Z, Golan-Katzav V, Wexler A, Gross D: Neuropsychological impairment from acute low-level exposure to carbon monoxide. Arch Neurol. 1998, 55 (6): 845-10.1001/archneur.55.6.845.CrossRefPubMed Amitai Y, Zlotogorski Z, Golan-Katzav V, Wexler A, Gross D: Neuropsychological impairment from acute low-level exposure to carbon monoxide. Arch Neurol. 1998, 55 (6): 845-10.1001/archneur.55.6.845.CrossRefPubMed
4.
Zurück zum Zitat Messier LD, Myers RAM: A Neuropsychological screening battery for emergency assessment of carbon-monoxide-poisoned patients. J Clin Psychol. 1991, 47 (5): 675-684. 10.1002/1097-4679(199109)47:5<675::AID-JCLP2270470508>3.0.CO;2-H.CrossRefPubMed Messier LD, Myers RAM: A Neuropsychological screening battery for emergency assessment of carbon-monoxide-poisoned patients. J Clin Psychol. 1991, 47 (5): 675-684. 10.1002/1097-4679(199109)47:5<675::AID-JCLP2270470508>3.0.CO;2-H.CrossRefPubMed
5.
Zurück zum Zitat Choi S: Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol. 1983, 40 (7): 433-10.1001/archneur.1983.04050070063016.CrossRefPubMed Choi S: Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol. 1983, 40 (7): 433-10.1001/archneur.1983.04050070063016.CrossRefPubMed
6.
Zurück zum Zitat Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, Orme JF, Thomas FO, Morris AH: Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002, 347 (14): 1057-1067. 10.1056/NEJMoa013121.CrossRefPubMed Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, Orme JF, Thomas FO, Morris AH: Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002, 347 (14): 1057-1067. 10.1056/NEJMoa013121.CrossRefPubMed
7.
Zurück zum Zitat Weaver LK, Valentine KJ, Hopkins RO: Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med. 2007, 176 (5): 491-497. 10.1164/rccm.200701-026OC.CrossRefPubMed Weaver LK, Valentine KJ, Hopkins RO: Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med. 2007, 176 (5): 491-497. 10.1164/rccm.200701-026OC.CrossRefPubMed
8.
Zurück zum Zitat Gale SD, Hopkins RO, Weaver LK, Bigler ED, Booth EJ, Blatter DD: MRI, quantitative MRI, SPECT, and neuropsychological findings following carbon monoxide poisoning. Brain Inj. 1999, 13 (4): 229-243. 10.1080/026990599121601.CrossRefPubMed Gale SD, Hopkins RO, Weaver LK, Bigler ED, Booth EJ, Blatter DD: MRI, quantitative MRI, SPECT, and neuropsychological findings following carbon monoxide poisoning. Brain Inj. 1999, 13 (4): 229-243. 10.1080/026990599121601.CrossRefPubMed
9.
Zurück zum Zitat Deschamps D, Geraud C, Julien H, Baud FJ, Dally S: Memory one month after acute carbon monoxide intoxication: a prospective study. Occup Environ Med. 2003, 60 (3): 212-216. 10.1136/oem.60.3.212.CrossRefPubMedPubMedCentral Deschamps D, Geraud C, Julien H, Baud FJ, Dally S: Memory one month after acute carbon monoxide intoxication: a prospective study. Occup Environ Med. 2003, 60 (3): 212-216. 10.1136/oem.60.3.212.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat McNair DM, Kahn RJ: Self-assessment of cognitive deficits. Assessment in Geriatric Psychopharmacology. Edited by: Crook T, Ferris S, Bartus R. 1983, New Canaan, CT: Mark Powley and Associates Inc, 137-143. McNair DM, Kahn RJ: Self-assessment of cognitive deficits. Assessment in Geriatric Psychopharmacology. Edited by: Crook T, Ferris S, Bartus R. 1983, New Canaan, CT: Mark Powley and Associates Inc, 137-143.
11.
Zurück zum Zitat Leplege A, Ecosse E, Verdier A, Perneger TV: The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998, 51 (11): 1013-1023. 10.1016/S0895-4356(98)00093-6.CrossRefPubMed Leplege A, Ecosse E, Verdier A, Perneger TV: The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998, 51 (11): 1013-1023. 10.1016/S0895-4356(98)00093-6.CrossRefPubMed
12.
Zurück zum Zitat Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59: 22-33.PubMed Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59: 22-33.PubMed
13.
Zurück zum Zitat Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2 Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2
14.
Zurück zum Zitat Chambers CA, Hopkins RO, Weaver LK, Key C: Cognitive and affective outcomes of more severe compared to less severe carbon monoxide poisoning. Brain Inj. 2008, 22 (5): 387-395. 10.1080/02699050802008075.CrossRefPubMed Chambers CA, Hopkins RO, Weaver LK, Key C: Cognitive and affective outcomes of more severe compared to less severe carbon monoxide poisoning. Brain Inj. 2008, 22 (5): 387-395. 10.1080/02699050802008075.CrossRefPubMed
15.
Zurück zum Zitat Ku H-L, Yang K-C, Lee Y-C, Lee M-B, Chou Y-H: Predictors of carbon monoxide poisoning-induced delayed neuropsychological sequelae. Gen Hosp Psychiatry. 2010, 32 (3): 310-314. 10.1016/j.genhosppsych.2009.11.005.CrossRefPubMed Ku H-L, Yang K-C, Lee Y-C, Lee M-B, Chou Y-H: Predictors of carbon monoxide poisoning-induced delayed neuropsychological sequelae. Gen Hosp Psychiatry. 2010, 32 (3): 310-314. 10.1016/j.genhosppsych.2009.11.005.CrossRefPubMed
Metadaten
Titel
Neuropsychological outcome after carbon monoxide exposure following a storm: a case-control study
verfasst von
Bérengère Pages
Mélanie Planton
Sophie Buys
Béatrice Lemesle
Philippe Birmes
Emmanuel Joseph Barbeau
Stéphanie Maziero
Laurie Cordier
Claudine Cabot
Michèle Puel
Michèle Genestal
François Chollet
Jérémie Pariente
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2014
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-14-153

Weitere Artikel der Ausgabe 1/2014

BMC Neurology 1/2014 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.